
Organization
Eli Lilly is rated high risk because it scored poorly across several corporate bias categories, including discriminatory philanthropy, employment protection, advocacy bias, funding, and political actions. The company is seen as prioritizing identity-based and politically driven initiatives over merit-based practices and core business objectives, raising concerns about governance and stakeholder alienation.